Utah Medical Products, Inc.
UTMD
$52.37
-$0.50-0.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.90M | 3.56M | 3.45M | 3.96M | 4.29M |
| Total Depreciation and Amortization | 730.00K | 740.00K | 693.00K | 683.00K | 1.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.00K | 0.00 | -107.00K | -112.00K | -339.00K |
| Change in Net Operating Assets | -828.00K | -447.00K | -1.28M | 749.00K | 345.00K |
| Cash from Operations | 2.94M | 3.86M | 2.76M | 5.28M | 5.33M |
| Capital Expenditure | -9.00K | -89.00K | -110.00K | -22.00K | -90.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 27.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -5.00K | -- | -- |
| Cash from Investing | -9.00K | -89.00K | -115.00K | 5.00K | -90.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 294.00K | 96.00K | 0.00 |
| Repurchase of Common Stock | -6.71M | -3.87M | -6.40M | -2.99M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.04M | -1.05M | -1.08M | -1.09M | -1.07M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -7.75M | -4.92M | -7.19M | -3.98M | -1.07M |
| Foreign Exchange rate Adjustments | -657.00K | 384.00K | -46.00K | -358.00K | 488.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.48M | -767.00K | -4.59M | 940.00K | 4.66M |